Cell Therapeutics Inc. (CTIC) Reports Q1 Loss of $0.20
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Financial Fact:
Net loss attributable to CTI: -29.18M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net loss attributable to CTI: -29.18M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q1 EPS of ($0.20), versus ($0.18) reported last year. Revenue for the quarter came in at $1.4 million, versus $1.1 million reported last year.
For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
